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Myeloid differentiation primary-response protein-88 (MyD88) is one of adaptor proteins mediating Toll-
like receptors (TLRs) signaling. Activation of MyD88 results in the activation of nuclear factor kappa B
(NFkB) and the increase of inﬂammatory responses. Evidences have demonstrated that TLRs signaling
contributes to cerebral ischemia/reperfusion (I/R) injury. However, the role of MyD88 in this mechanism
of action is disputed and needs to be clariﬁed. In the present study, in a mouse model of cerebral I/R, we
examined the activities of NFkB and interferon factor-3 (IRF3), and the inﬂammatory responses in
ischemic brain tissue using ELISA, Western blots, and real-time PCR. Neurological function and cerebral
infarct size were also evaluated 24 h after cerebral I/R. Our results showed that NFkB activity increased in
ischemic brains, but IRF3 was not activated after cerebral I/R, in wild-type (WT) mice. MyD88 deﬁcit
inhibited the activation of NFkB, and the expression of interleukin-1b (IL-1b), IL-6, Beclin-1 (BECN1),
pellino-1, and cyclooxygenase-2 (COX-2) increased by cerebral I/R compared with WT mice. Interestingly,
the expression of interferon Beta 1 (INFB1) and vascular endothelial growth factor (VEGF) increased in
MyD88 KO mice. Unexpectedly, although the neurological function improved in the MyD88 knockout
(KO) mice, the deﬁcit of MyD88 failed to reduce cerebral infarct size compared to WT mice. We
concluded that MyD88-dependent signaling contributes to the inﬂammatory responses induced by ce-
rebral I/R. MyD88 deﬁcit may inhibit the increased inﬂammatory response and increase neuroprotective
signaling.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Stroke remains one of the leading causes of death and the most
common cause of disability in adults [1]. Although the pathogenesis
for cerebral ischemia/reperfusion (I/R) injury is multifactorial,
increasing experimental evidence suggests that the inﬂammatory
responses initiated by the immune system play a vital role in the
pathophysiological mechanisms underlying cerebral I/R injury [2].
Toll-like receptors (TLRs) are a family of proteins that play a key role
in the immune/inﬂammation system. TLRs can recognize both
pathogen and/or damage-associated molecular patterns and theny, The Afﬁliated Hospital of
Inc. This is an open access article uactivate the cytosolic adaptor molecules that bind to the intracel-
lular domain of TLRs, which induce immunity and inﬂammation
[3,4]. The adaptor proteins in TLRs signaling pathway mainly
include myeloid differentiation primary-response protein-88
(MyD88) and TIR-domain-containing adapter-inducing interferon-
b (TRIF). Other adaptors, MyD88 adaptor-like (MAL), TRIF-related
adaptor molecule (TRAM), and sterile-alpha and armadillo motif
containing protein (SARM), were also identiﬁed [5]. After being
activated by ligands, the adaptors recruit serial downstream ki-
nases, results in nuclear translocation of nuclear factor kappa B
(NFkB) and/or the activation of interferon regulatory factor 3 (IRF3),
and then induces the transcription of genes associated with innate
immunity and inﬂammation [6]. Clinical and experimental studies
have demonstrated that TLR-mediatedsignal pathways have been
implicated in the pathophysiology of cerebral ischemic injury [4,7].
Our previous studies have also shown that TLR4 signaling pathwaynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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models [8,9]. We also found that antagonist for TLR4 attenuates
cerebral I/R injury [10]. However, since TLR4 signaling is mediated
by both MyD88 and TRIF, which one attributes to the effect of TLR4
on cerebral I/R injury needs to be clariﬁed. In a previous study of
ours, the TRIF gene knockout mice were used to establish cerebral I/
Rmodel, and the result indicated that the TRIF-dependent signaling
pathway is not required for acute cerebral I/R injury [11]. The exact
role of MyD88-dependent signaling in cerebral I/R injury is
disputed [12,13], which is a critical question for understanding the
mechanisms of cerebral I/R injury and ﬁnding new targets for the
treatment for ischemic stroke. In the present study, the MyD88
knockout (KO) mice and wild type (WT) control mice were used to
evaluate the role of MyD88-dependent pathway in cerebral I/R
injury. The role of MyD88 in the inﬂammatory responses induced
by cerebral I/R was investigated.
2. Materials and methods
2.1. Experimental animals
The MyD88 knockout (MyD88KO) mice and wild type C57BL/6J
control mice (WT) were purchased from Jackson laboratory, bred
and maintained in the Division of Laboratory Animal Resources at
Emory University. The male mice with body weights of 25e30 g
were used in the present study. All experiments were conducted in
accordance with the standards and procedures of the American
Council on Animal Care Institutional Animal Care and Use Com-
mittee of Emory University. Mice were randomly assigned to four
groups: wild type sham control (WS, n ¼ 9), wild type mice sub-
jected to focal cerebral ischemia/reperfusion (I/R) (WIR, n ¼ 23),
MyD88 knockout sham control (MS, n ¼ 9), and MyD88 knockout
mice subjected to focal cerebral I/R (MIR, n¼ 24). In each I/R group,
5micewere killed 4 h after cerebral I/R for use of real-time PCR, and
5 mice were killed 24 h after cerebral I/R for use of ELISA and
Western blots. Other remaining mice in each group were killed via
perfusion 24 h after cerebral I/R for the evaluation of infarct
volume.
2.2. Induction of focal cerebral ischemia/reperfusion (I/R)
Focal cerebral ischemia was induced by occlusion of the middle
cerebral artery (MCAO) according to our previous reported
methods [11]. Brieﬂy, mice were subjected to anesthesia by inha-
lation of 1.5%e2% isoﬂurane driven by 100% oxygen ﬂow. The tra-
chea was intubated and the lungs were mechanically ventilated
(110 breaths/min, tidal volume: 0.5 ml). Body temperature was
regulated at 37 Cwith a temperature control system. Following the
skin incision, a coated 6-0 ﬁlament (Doccol Corp., Redlands, CA,
USA) was introduced into the internal carotid artery (ICA) via
external carotid artery (ECA) and advanced 11 mm from the carotid
bifurcation (cerebral ischemia started). After ischemia for 60 min,
the ﬁlament was withdrawn and the reperfusion started. The ECA
was tightened, the skin was closed, and anesthesia was dis-
continued. The ischemic and reperfusion conditions were
conﬁrmed by regional cerebral blood ﬂow (rCBF) detected by a laser
Doppler cerebral ﬂow meter (moorVMS-LDF, Moor Instruments,
Delaware, DE, USA). The mice were allowed to recover in pre-
warmed cages. Control mice underwent the same process
without MCAO.
2.3. Evaluation of neurological score
Neurological scores were evaluated by an investigator blinded to
group identity using a neurological evaluation instrument reportedpreviously [10]. Brieﬂy, the scoring system included ﬁve principal
tasks: spontaneous activity over a 3-min period (0e3), symmetry of
movement (0e3), open-ﬁeld path linearity (0e3), beamwalking on
a 3 cm  1 cm beam (0e3), and response to vibrissae touch (1e3).
2.4. Assessment of cerebral infarct volume size
Cerebral infarct size was evaluated according to previous
methods [11]. Brieﬂy, 24 h after cerebral I/R, the mice were trans-
cardiacally perfused with cold saline followed by 4% para-
formaldehyde in PBS (PH¼ 7.4) via the ascending aorta. Brains were
removed and post-ﬁxed in 4% paraformaldehyde for 48 h and then
stored at 4 C in a solution of 30% sucrose-PBS for two days. The
brains were embedded in OCT compound and sectioned coronally
to 10 mm-thick slices starting from the frontal pole at an interval of
1 mm. The sections were stained with 0.5% cresyl violet (Nissl
staining). The infarct areas deﬁned as the area showing reduced
Nissl staining under light microscope were traced and quantiﬁed
with image-analysis system. The areas of infarction in both hemi-
spheres were calculated for each brain slice. Infarct volume
adjusted for edema was calculated by dividing the infarct volume
by the edema index, which was calculated by dividing the total
volume of the left hemisphere by the total volume of the right
hemisphere. Infarct volumes are expressed as percentage of the
total brain volume [10,11].
2.5. Enzyme-linked immunosorbent assay (ELISA)
Nuclear proteins were isolated from ischemic hemispheres
harvested 24 h after cerebral ischemia. The activities of nuclear
factor kappa B (NFkB) and interferon regulatory Factor 3 (IRF-3),
and the protein levels of interleukin-1b (IL-1b) and interleukin-6
(IL-6) were examined by ELISA as described previously using an
ELISA kit (Active Motif. Inc.) [11]. According to manufacturer in-
structions, 15 mg of nuclear proteins was used for detection, and the
absorbance was read on a spectrophotometer with a wavelength of
450 nmwith a reference wavelength of 655 nm. The concentration
of the detected protein was calculated according to the standard
curve.
2.6. Western Blots
According to our previous method [10], cellular proteins were
prepared from the ischemic hemispheres (left) harvested 24 h after
cerebral I/R. The proteins were electrophoresed with SDS-
polyacrylamide gel, and transferred onto Hybond ECL membranes
(Amersham Pharmacia, Piscataway, NJ). The ECL membranes were
incubated with the appropriate primary antibody followed by in-
cubationwith peroxidase-conjugated secondary antibodies. Signals
were detected with the ECL system (Amersham Pharmacia) and
quantiﬁed by scanning densitometry and computer-assisted image
analysis.
2.7. Real-time PCR
Total RNA was isolated from ischemic hemisphere (left) har-
vested 4 h after cerebral I/R using a standard protocol. The synthesis
of cDNA was performed using iScript™ Reverse Transcription
Supermix for RT-qPCR (Bio-Rad, #170e8841) according to its pro-
tocol at 42 C for 15 min and then stopped immediately by heating
at 95 C for 5 min. RT-PCR TaqMan® Gene Expression Assays were
performed using TaqMan real-time PCR primers and probes for
mouse. The housekeeping gene (b-actin) was used for internal
normalization. The real time PCR reaction was performed on
7900HT Fast Real-time PCR System (ABI, USA). Each sample was
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was set as follows: stage 1: 95 C for 10 min, stage 2: 95 C for 15 s
(for denaturation) followed by 60 C (transcription) for 1 min
repeated for 40 cycles, and stage 3: 95 C for 15 s, 60 C for 15 s, and
95 C for 15 s. The double delta Ct (DDCt) for each gene of interest
(GOI) was calculated by deducting the average DCt of GOI in the
sham group from the DCt of each GOI. The fold-change of each GOI
compared to the sham group was calculated as 2DDCt.2.8. Statistical analysis
Continuous scale measurements were expressed by the mean
and standard error of the mean (S.E.M) for each group. Group
comparisons for infarct size were done with the t-test (applied to
score values). One-way ANOVA and the least signiﬁcant difference
procedurewere used to assess the effectiveness of intervention and
group differences for the neurological scores, the activities of NFkB
and IRF-3, and the levels of proteins andmRNA. Probability levels of
0.05 or smaller were considered signiﬁcant.3. Results
3.1. Brain infarction volume and neurological score
The results showed that cerebral I/R induced signiﬁcant brain
infarction in the ischemic hemisphere. However, there was no
signiﬁcant difference in infarct volume between MIR group and
WIR group (p > 0.05, Fig. 1A). Cerebral I/R decreased the neuro-
logical score, which was signiﬁcantly improved in MyD88 KO mice
compared with WT mice (p < 0.05, Fig. 1B).3.2. ELISA
To evaluate the changes of the transcript factors in MyD88-
dependent pathway and TRIF-dependent pathway after cerebral
I/R, the activities of NFkB and IRF-3 were examined by the
method of ELISA. The results showed that the activity of NFkB
signiﬁcantly increased after cerebral I/R, which was inhibited in
MyD88KO mice (p < 0.05, Fig. 2A). However, the activity of IRF-3
did not show signiﬁcant changes after cerebral I/R in WT and
MyD88KO mice (p > 0.05, Fig. 2B). In addition, the levels of
downstream cytokines in MyD88-dependent pathway, inter-
leukin-1b (IL-1b) and interleukin-6 (IL-6), signiﬁcantly increased
after cerebral I/R, which were inhibited in MyD88KO mice
(p < 0.05, Fig. 2C and D).Fig. 1. Cerebral infarction volume and neurological score: The results showed that cereb
was no signiﬁcant difference in infarct volume between MIR group and WIR group (p >
improved in MyD88 KO mice compared with WT mice (p < 0.05, Fig. 1B).3.3. Real-time PCR
To investigate whether the inﬂammatory response is mediated
via MyD88-dependent pathway in ischemic brain, some inﬂam-
matory mediators were evaluated by real-time PCR. As shown in
Fig. 3, the mRNA levels of Pellino-1 and COX-2 increased signiﬁ-
cantly 4 h after cerebral I/R in WT mice compared to sham-
operated controls. MyD88 deﬁciency inhibited the increased
expression of Pellino-1 and COX-2 (p < 0.05, Fig. 3A and B). How-
ever, although the mRNA of cluster of differentiation (CD14), a
pattern recognition receptor, was signiﬁcantly up-regulated after
cerebral I/R, MyD88 deﬁcit did not reduce the expression of CD14
compared withWTmice (p > 0.05, Fig. 3C). The mRNA of interferon
Beta 1 (INFB1) increased after cerebral I/R, which, interestingly, was
more up-regulated in MyD88 KO mice compared with WT mice
(p < 0.05, Fig. 3D).
3.4. Western Blots
Becline-1 (BECN1) and vascular endothelial growth factor
(VEGF) were detected by the method of Western Blots. As shown in
Fig. 4, the expression of BECN1 increased in WT mice after cerebral
I/R, compared with WT control (p < 0.05), which was inhibited in
MyD88KO mice (Fig. 4A). The expression of VEGF was not signiﬁ-
cantly affected by cerebral I/R in WT mice, which, interestingly,
signiﬁcantly up-regulated in MyD88KO mice with or without ce-
rebral ischemia (Fig. 4B).
4. Discussion
Stroke occurs as a result of loss of blood supply or inadequate
blood ﬂow to a particular part of the brain which causes tissue
damage [14]. The reperfusion of the blood supply can induce a
further injury in the ischemic tissue, called ischemia/reperfusion
injury. The mechanisms underlying the cerebral I/R injury are
complex and involved in multiple factors, in which immunoin-
ﬂammatory responses in ischemic brain greatly contribute to the
brain injury [15,16]. Toll-like receptors (TLRs) are a family of
transmembrane receptors responsible for recognition and initia-
tion of a response to invading microbes by the immune system [5].
Previous studies have demonstrated that TLRs-mediated signaling
pathways play a central role in the pathophysiology of cerebral
ischemic injury by stimulating various cellular and molecular
events, leading to exacerbation of brain tissue damage [9,17].
Functional TLR signal transduction relies on receptor dimerization,
and the presence of accessory proteins and co-receptors [18].ral I/R induced signiﬁcant brain infarction in the ischemic hemisphere. However, there
0.05, Fig. 1A). Cerebral I/R decreased the neurological score, which was signiﬁcantly
Fig. 2. The results from ELISA: The results showed that the activity of NFkB signiﬁcantly increased after cerebral I/R, which was inhibited in MyD88KO mice (p < 0.05, Fig. 2A).
However, the activity of IRF-3 did not show signiﬁcant changes after cerebral I/R in WT and MyD88KO mice (p > 0.05, Fig. 2B). In addition, interleukin-1b (IL-1b) and interleukin-6
(IL-6) signiﬁcantly increased after cerebral I/R, which were inhibited in MyD88KO mice (p < 0.05, Fig. 2C and D).
Fig. 3. The results from real-time PCR: As shown in the ﬁgures, the mRNA levels of Pellino-1 and COX-2 increased signiﬁcantly 4 h after cerebral I/R in WT mice compared to
sham-operated controls. MyD88 deﬁciency inhibited the increased expression of Pellino-1 and COX-2 (p < 0.05, Fig. 3A and B). However, although the mRNA of cluster of dif-
ferentiation (CD14), a pattern recognition receptor, was signiﬁcantly up-regulated after cerebral I/R, MyD88 deﬁcit did not reduce the expression of CD14 compared with WT mice
(p > 0.05, Fig. 3C). The mRNA of interferon Beta 1 (INFB1) increased after cerebral I/R, which, interestingly, was more up-regulated in MyD88 KO mice compared with WT mice
(p < 0.05, Fig. 3D).
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Fig. 4. The results from Western Blots: Becline-1 (BECN1) and vascular endothelial growth factor (VEGF) were detected. The results showed that the expression of BECN1
increased in WT mice after cerebral I/R, compared with WT control (p < 0.05), which was inhibited in MyD88KOmice (Fig. 4A). The expression of VEGF was not signiﬁcantly affected
by cerebral I/R in WT mice, which, interestingly, signiﬁcantly up-regulated in MyD88KO mice with or without cerebral ischemia (Fig. 4B).
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kinases and then phosphorylates the inhibitor of kB (IkB), resulting
in nuclear translocation of NF-kB and the transcription of genes
associated with innate immunity and inﬂammation [6,19]. In the
present study, by using MyD88KO mice to establish cerebral I/R
model, we obtained the following novel ﬁndings.
4.1. TLRs-mediated NF-kB signaling in ischemic brain was mediated
through MyD88-dependent pathway
The activity of NF-kB, the downstream nuclear factor mediated
by MyD88-dependent pathway, and the activity of IRF3, a down-
stream nuclear factor mediated by TRIF-dependent pathway (also
called MyD88-independent pathway) were detected. Our data
showed that the activity of NF-kB signiﬁcantly increased in
ischemic brain tissue inWTmice, which was inhibited inMyD88KO
mice. The activity of IRF3 did not increase in ischemic brain, which
was consistent with our previous report [11], and was not affected
by MyD88 deﬁciency. The data strongly indicated that the activa-
tion of TLRs-mediated NF-kB signaling in ischemic brain was
mainly mediated through MyD88-dependent pathway, and modi-
ﬁcation of MyD88 inhibited the activation of NF-kB after cerebral I/
R. Cluster of differentiation 14 (CD14) acts as a co-receptor (along
with the Toll-like receptor TLR4 and Lymphocyte antigen 96) and
informs the CD14/TLR4/MD2 receptor complex. This complex
transduces a signal via MyD88, resulting in the activation of NF-kB
[20e22]. Our data showed that the mRNA of CD14 signiﬁcantly
increased in ischemic brain, and that MyD88 deﬁciency did not
change the expression of CD14 compared with WT mice, which
demonstrated MyD88KO did not affect its up-stream co-receptor.
4.2. Inﬂammatory responses induced by cerebral I/R were mediated
through MyD88-dependent pathway
Activation of NF-kB results in the transcription of RNA and the
protein expression of several cytokines, such as interleukins (IL)
and cyclooxygenase (COX), as well as downstream protein kinases,
such as pellino E3 uniquitin ligases (pellino), which signals via
MyD88, and facilitates MyD88-dependent signaling and proin-
ﬂammatory cytokines [23]. In our study, the IL-1b, IL-6, pellino-1,
COX2, and Beclin-1 (BECN1) were detected by the methods of
ELISA, real-time PCR, andWestern Blot. The results showed that the
protein levels of IL-1b, IL-6, and BECN1, and the mRNA levels of
pellino-1 and COX-2 were signiﬁcantly up-regulated by cerebral I/Rin WTmice compared with sham control. The increased IL-1b, IL-6,
BECN1, pellino-1, and COX-2 were signiﬁcantly inhibited in MyD88
KO mice subjected to cerebral I/R compared with WT mice. The
results strongly demonstrate that in cerebral I/R induce inﬂam-
matory responses, which are mediated via MyD88-dependent
pathway, modiﬁcation of MyD88 may inhibit neuroinﬂammatory
in ischemic brain.
4.3. MyD88 deﬁciency increased neuroprotective signaling
INFB is a cytokine in the interferon family. Recent study in-
dicates that the INFB exerts a protective effect against ischemic
stroke through its anti-inﬂammatory properties [24]. VEGF is a
signal protein that stimulates vasculogenesis and angiogenesis.
Several studies indicated that VEGF treatment improved neuro-
logical deﬁcit scores, inhibited apoptosis in the basal ganglia and
cortex, increasedmicrovessel generation, and improved the growth
and proliferation of vascular endothelial cells [25,26]. Our results
demonstrated that the mRNA of interferon Beta 1 (INFB1) and the
protein of vascular endothelial growth factor (VEGF) increased in
MyD88KO mice compared with WT mice. Although the mecha-
nisms underlying the up-regulation of INFB and VEGF in MyD88KO
mice are not clear, our data suggested that MyD88-dependent
pathway had crosstalk with some neuroprotective signaling.
MyD88 deﬁciency increased the neuroprotective signaling in
ischemic brain.
4.4. MyD88KO failed to reduce cerebral infarction after I/R
Although the inhibited inﬂammatory responses and improved
neurological function were observed in MyD88KO mice, the brain
infarction volume did not show signiﬁcant difference between WT
mice and MyD88 mice. Another study also showed that MyD88 KO
did not reduce cerebral infarction. Possible explanations for this
phenomenon include the following: 1. The time points in this study
was not the optimal time for the detection of infarct volume.
Multiple time observations and image methods (CT or MRI) for
detection of infarct size are needed in further studies. 2. There are
multiple factors involving the mechanisms of cerebral I/R injury.
Inﬂammatory response is not the only cause inducing brain dam-
age. Inhibition of inﬂammation by MyD88 deﬁcit is not enough to
show a signiﬁcantly reduced infarct size.
In summary, our data indicates that MyD88-dependent
signaling contributes to the inﬂammatory responses induced by
X. Ye et al. / Biochemical and Biophysical Research Communications 480 (2016) 69e7474cerebral I/R. MyD88 deﬁcit may inhibit the increased inﬂammatory
response and increase neuroprotective signaling.
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